Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06584383 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06584383 · ClinicalTrials.gov record · last posted 2026-05-06

A Prospective, Randomized, Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR-guided Focused Ultrasound Subthalamotomy in Patients With Early-Stage Parkinson's Disease

StatusActive, Not Recruiting
PhaseNot applicable
SponsorInSightec
Started2024-08-01
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This prospective, randomized, multicenter study aims to evaluate in Early-Stage Parkinson's Disease (ESPD) patients the safety and effectiveness of treatment with Exablate MRgFUS subthalamotomy vs best medical treatment.

Protocol amendment history 1 change detected by DataLookout

2026-05-07
Trial status changed: Recruiting → Active, Not Recruiting
Trial Details
NCT Number NCT06584383
Lead Sponsor InSightec
Conditions Parkinson Disease
Enrollment 67 participants
Start Date 2024-08-01
Primary Completion 2027-09 (estimated)
Study Completion 2029-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-06